Cite
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
MLA
Hartkopf, Andreas D., et al. “Treatment Landscape of Advanced Breast Cancer Patients with Hormone Receptor Positive HER2 Negative Tumors - Data from the German PRAEGNANT Breast Cancer Registry.” Breast (Edinburgh, Scotland), vol. 37, Feb. 2018, pp. 42–51. EBSCOhost, https://doi.org/10.1016/j.breast.2017.10.002.
APA
Hartkopf, A. D., Huober, J., Volz, B., Nabieva, N., Taran, F.-A., Schwitulla, J., Overkamp, F., Kolberg, H.-C., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lux, M. P., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wimberger, P., … Schneeweiss, A. (2018). Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry. Breast (Edinburgh, Scotland), 37, 42–51. https://doi.org/10.1016/j.breast.2017.10.002
Chicago
Hartkopf, Andreas D, Jens Huober, Bernhard Volz, Naiba Nabieva, Florin-Andrei Taran, Judith Schwitulla, Friedrich Overkamp, et al. 2018. “Treatment Landscape of Advanced Breast Cancer Patients with Hormone Receptor Positive HER2 Negative Tumors - Data from the German PRAEGNANT Breast Cancer Registry.” Breast (Edinburgh, Scotland) 37 (February): 42–51. doi:10.1016/j.breast.2017.10.002.